Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00573924 · ClinicalTrials.gov registry record · NA
Trial of Oral Versus Intravenous Proton Pump Inhibitor on Intragastric pH in Patients With Bleeding Ulcers
A NA study of Peptic Ulcer Hemorrhage, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 66
- Enrollment target
- 1
- Study location
NCT00573924: Completed NA study of Peptic Ulcer Hemorrhage, sponsored by University of Southern California.
NCT00573924 is a NA study of Peptic Ulcer Hemorrhage that has completed, run by University of Southern California. The registered enrollment target is 66 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00573924, a NA study of Peptic Ulcer Hemorrhage, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients with bleeding ulcers identified by endoscopy will be randomly assigned to receive an acid-blocking drug (called a proton pump inhibitor \[PPI\]) either by mouth every 3 hours for 24 hours or intravenously (IV) by constant infusion for 24 hours. A pH probe in the stomach will be used to determine intragastric pH (a measure of the acid production in the stomach) at baseline and during the 24 hours of therapy. The purpose of the study is to determine if the continuous intravenous administration of the drug provides better reduction of acid in the stomach than the oral administration.
Conditions Studied
Interventions
- DRUG Proton pump inhibitor (lansoprazole)
Study Locations (1)
California
- L.A. County + U.S.C. Medical Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2006-02 |
| Est. Completion | 2007-12 |
| Phase | NA |
What the finished NCT00573924 record still lists
NCT00573924 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Peptic Ulcer Hemorrhage appearing as the primary indexed condition, and to 1 intervention - of which Proton pump inhibitor (lansoprazole) is the first listed.
NCT00573924 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00573924 about?
NCT00573924 is a clinical study titled "Trial of Oral Versus Intravenous Proton Pump Inhibitor on Intragastric pH in Patients With Bleeding Ulcers". Patients with bleeding ulcers identified by endoscopy will be randomly assigned to receive an acid-blocking drug (called a proton pump inhibitor \[PPI\]) either by mouth every 3 hours for 24 hours or intravenously (IV) by constant infusion for 24 hours. A pH probe in the stomach will be used to dete...
What is the current status of trial NCT00573924?
This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2006-02. Estimated completion is 2007-12.
What conditions does trial NCT00573924 study?
This clinical trial studies the following conditions: Peptic Ulcer Hemorrhage.
What interventions are being tested in trial NCT00573924?
The interventions under investigation include: Proton pump inhibitor (lansoprazole) (DRUG).
Who is sponsoring clinical trial NCT00573924?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00573924 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peptic Ulcer Hemorrhage
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00573924's enrollment target sits among peer trials
66 1139th of 2000 higher than 857 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia